1. Lawthom C, Smith PE, Wild JM. Nasal retinal nerve fiber layer attenuation: a biomarker for vigabatrin toxicity. Ophthalmology. 2009; 116:565–571.
2. Akçakaya AA, Gökçeer S, Erbil HH, et al. Detecting retinal vigabatrin toxicity in patients with partial symptomatic or cryptogenic epilepsy. Eur J Ophthalmol. 2010; 20:763–769.
3. Clayton LM, Dévilé M, Punte T, et al. Retinal nerve fiber layer thickness in vigabatrin-exposed patients. Ann Neurol. 2011; 69:845–854.
4. Moseng L, Sæter M, Mørch-Johnsen GH, et al. Retinal nerve fibre layer attenuation: clinical indicator for vigabatrin toxicity. Acta Ophthalmol. 2011; 89:452–458.
5. Clayton LM, Devile M, Punte T, et al. Patterns of peripapillary retinal nerve fiber layer thinning in vigabatrin-exposed individuals. Ophthalmology. 2012; 119:2152–2160.
6. Gomceli YB, Dogan B, Genc F, et al. Optical coherence tomography parameters in patients with photosensitive juvenile myoclonic epilepsy. Seizure. 2016; 35:36–40.
7. Balestrini S, Clayton LM, Bartmann AP, et al. Retinal nerve fibre layer thinning is associated with drug resistance in epilepsy. J Neurol Neurosurg Psychiatry. 2016; 87:396–401.
8. Ropper A, Samuels MA. Epilepsy and Other Seizure Disorders. Ropper A, Samuels MA. Adams and Victor's Principles of Neurology. 9th ed. New York: McGraw Hill;2009. p. chap. 16.
9. Joseph JM, Louis S. Transient ictal cortical blindness during middle age. A case report and review of the literature. J Neuroophthalmol. 1995; 15:39–42.
10. Lee SK, Lee SY, Kim DW, et al. Occipital lobe epilepsy: clinical characteristics, surgical outcome, and role of diagnostic modalities. Epilepsia. 2005; 46:688–695.